Gainey McKenna & Egleston Investigates The Officers And Directors Of Frequency Therapeutics, Inc. (FREQ)

NEW YORK, July 08, 2022 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that it is investigating the officers and directors of Frequency Therapeutics, Inc. ("Frequency" or the "Company") (NASDAQ:FREQ ) for potential breaches of fiduciary duties, waste of corporate assets, and unjust enrichment between November 16, 2020 and March 22, 2021. A securities class action complaint is pending in ... Full story available on Benzinga.com